Premium DNA Test from CircleDNA

The page shows current regional offer blocks and claims free delivery and returns, and the terms disclose kit expiry, sample return timing, and a separate exchange and refund policy. The rendered one-kit offer is not internally consistent and total cost, taxes, eligibility, and exact refund conditions are not fixed by the reviewed pages.

CircleDNA publishes a broad 500-plus report and 20-plus category claim spanning several health and lifestyle areas. Coverage for a particular buyer question remains only partly auditable because the exact Premium gene inventory is not public and the consent identifies untested variant classes and regions.

The documented report categories are relevant to inherited-risk, nutrition, fitness, drug-response, and wellness questions, and the consent gives explicit non-diagnostic boundaries. Relevance remains bounded because category-specific evidence, intended-use validation, population fit, and action thresholds are not fully documented for the Premium product.

The provider describes app-based reports, personalized guidance, and a complimentary genetic consultation, while the consent directs users to clinicians and explains uncertainty and non-diagnostic limits. No official sample report or full report-level presentation of ranges, uncertainty, and follow-up steps was located.

The method is identifiable as targeted NGS on a NovaSeq 6000 system and the consent states variant classes, technical exclusions, and a bounded sensitivity and specificity claim. The performing laboratory name, accreditation scope, target gene list, and product-specific validation evidence are not disclosed in the reviewed public pages.

The workflow is simple on its face: order online, collect saliva at home, return through the provider route, and view app results after the stated 18 business days. Country-specific availability, rejection handling, exact return logistics, and the turnaround start point remain unknown.

The legal privacy policy and informed consent cover genetic-data processing, operational sharing, retention, security controls, sample use, research opt-ins, and consumer rights. A fixed deletion schedule and sample-destruction control are not stated, and the privacy pages use different levels of specificity about outside processing.

Product, method, specimen route, broad scope, consent limitations, privacy practices, and sample terms are available from official pages. Evaluation is materially limited by the missing exact gene list, named performing laboratory, accreditation scope, product-specific validation record, and inconsistent one-kit offer blocks on the rendered page.